New Innovation Gives Clinical Pathology Laboratories Opportunity to Use Dried Blood Spot Specimens in Medical Lab Testing
More sensitive analytical technologies allow medical laboratories to perform more sophisticated tests using tiny blood specimens on paper
New breakthroughs are creating the opportunity to use “dried blood spot” (DBS) technology in an expanded number of pathology and clinical laboratory testing applications. The latest innovation was developed in the United Kingdom and allows more sophisticated applications of this decades-old screening method.
This new technology was announced in a press release that discussed the new screening method. It was developed by a research team in the UK as a rapid method for simultaneously screening patients for a range of genetic and acquired clinical conditions from a single dried blood spot.
The team consisted of researchers at King’s College of London, together with clinicians from Guy’s and St. Thomas’ NHS Foundation Trust. The college and the two hospitals are part of King’s Health Partners, one of the UK’s five Academic Health Sciences Centers.